The activities of insulin-like growth factor (IGF)-I and -II are regulated by IGF binding proteins (IGFBPs).
INTRODUCTION
Insulin-like growth factors (IGF)-I and -II have potent anabolic and mitogenic actions in vivo and in vitro, mediated primarily through the type 1 IGF receptor (1) . Their biological activities are regulated by six different, homologous IGF-binding proteins (IGFBP-1 to -6), which bind the IGFs with high affinities and thus, in some cases, prevent them from binding to the receptor (2) . As a regulatory mechanism, proteolytic cleavage in the central region of the IGFBPs causes dissociation of bound IGF (3) .
The identities of the proteinases responsible for cleavage in vitro of individual IGFBPs are often unknown. However, it has recently been established that the metalloproteinase pregnancy-associated plasma protein-A (PAPP-A) is responsible for cleavage of IGFBP-4 (4, 5) . This was first found using conditioned medium from human fibroblasts and osteoblasts (4) , but it has also been demonstrated that PAPP-A is the IGFBP-4 proteinase secreted from vascular smooth muscle cells (6, 7) and granulosa cells (8) . In addition, recent data suggests the involvement of PAPP-A and IGFBP-4 in human implantation (9) , and in ovarian follicular development (10) (11) (12) . Furthermore, it has been found that IGFBP-5 is also a PAPP-A substrate, but unlike the cleavage of IGFBP-4 by PAPP-A, which is dramatically increased by IGF, the cleavage of IGFBP-5 by PAPP-A is slightly inhibited by IGF (13) . Where, and to what extent, PAPP-A functions as an IGFBP-5 proteinase in vivo is currently not known. Interestingly, IGFBP-5, but not IGFBP-4, is known to interact with the cell surface (14) .
The metzincin superfamily of metalloproteinases is a diverse group of zinc endopeptidases, which includes the astacins, the reprolysins, the serralysins, and the matrix metalloproteinases (MMPs) (15) . The proteolytic domains of metzincins have common sequence elements, including an elongated zinc-binding motif (HEXXHXXGXXH) (16) , and they share a common fold, but specific structural features distinguish Adhesion of pregnancy-associated plasma protein-A, PAGE 8 5'-ctgcattcctGTGACCTGTGACCCACCTC-3' for chim6 (PAPP-A residues 1-1344 + 1413-1627), 5'-AGCACTGGCCttgcagattctcacacaact-3' and 5'-gaatctgcaaGGCCAGTGCTCGGTTCCAAAC-3' for chim7
(PAPP-A residues 1-1412 + 1476-1627), 5'-AGCACTGGCCttgcagattctcacacaact-3' and 5'-gaatctgcaaGGCCAGTGCTCGGTTCCAAAC-3' for chim8 (PAPP-A residues 1-1344 + 1476-1627), and 5'-CGAGGCACATcaacttgcagtagacttcag-3' and 5'-ctgcaagttgATGTGCCTCGCTCCAC-3' for chim9 (PAPP-A residues 1-1214 + 1345-1475). All plasmid constructs were verified by sequence analysis.
Tissue Culture and Transfection -Human embryonic kidney 293T cells (293tsA1609neo) were maintained in high glucose DMEM medium supplemented with 10% fetal bovine serum, 2 mM glutamine, nonessential amino acids, and gentamicin (Invitrogen) (5) . Cells were plated onto 6 cm tissue culture dishes, and were transfected 18 h later by calcium phosphate co-precipitation using 10 µg of plasmid DNA (5) .
Plasmid constructs used for transfection were: pcDNA3.1-proPAPP-A, pcDNA3.1-PAPP-A, pPA2
(encoding preproPAPP-A2), pA-C1210STOP, and chimeric PAPP-A/PAPP-A2 constructs as detailed above.
In other transfection experiments, cells were co-transfected with plasmid DNA encoding the αM (CD11b) and the β2 (CD18) integrin subunits (28) , which associate as the leukocyte integrin Mac-1 on the cell surface. Other cells lines (JAR, BHK-21, JEG-3) were obtained from American Type Culture Collection (ATCC) and cultured in the same medium. A primary culture of normal human skin fibroblasts was obtained and cultured as described (29) .
ELISA -The levels of recombinant PAPP-A in the supernatants were measured by a standard sandwich ELISA. PAPP-A polyclonal antibodies, anti(PAPP-A/proMBP) (25) , were used for capture, and a PAPP-A monoclonal antibody (mAb 234-2) (30) followed by peroxidase conjugated anti(mouse IgG) (P260, DAKO) for detection. PAPP-A/proMBP purified from pregnancy serum (25) was used to establish standard curves.
Flow Cytometry -Transfected 293T cells were detached with phosphate-buffered saline (PBS) containing 5 mM EDTA 48 h post transfection, and washed with cold L15 medium (Sigma) containing 2% FBS (L15/FBS), and incubated on ice with primary antibody against PAPP-A (234-2 or 234-5 (30) , in all cases with similar results) or integrin Mac-1 (2LPM19c, DAKO) at 10 µg/ml for 1 h. After washing three by guest on http://www.jbc.org/
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Adhesion of pregnancy-associated plasma protein-A, PAGE 9 times in L15/FBS, the cells were incubated with fluorescein isothiocyanate goat antimouse IgG (Zymed) diluted 1 to 50 for 30 min. After three washes, the cells were suspended in PBS with 2% paraformaldehyde and analyzed on a Becton-Dickinson flow cytometer. At least 5.000 cells were analyzed. In other experiments, non-transfected cells (293T, JAR, BHK-21, JEG-3, human fibroblasts) were detached with PBS/5 mM EDTA 24 h after splitting, incubated on ice for 1 h with culture supernatant (100 µl) containing 0-5 µg/ml PAPP-A or 0-200 µg/ml PAPP-A/proMBP complex purified from pregnancy serum (25) , and then washed prior to incubation with primary antibody. The number of cells were kept constant in all series of experiments. The effect of glycosaminoglycans on PAPP-A surface binding was studied by preincubation of the PAPP-A containing culture supernatant for 30 min on ice with 0-100 µg/ml low molecular weight (approximately 6000 g/mol) heparin (Sigma), heparan sulfate (16500 g/mol), chondroitin sulfate (14900 g/mol), or dermatan sulfate (17800 g/mol) (gifts of Kristian Johansen, LEO Pharma). purified from a culture of Flavobacterium heparinum, a gift of Kristian Johansen) was studied by preincubation of cells for 1 h with 0.3 mIU/ml of enzyme at 37 °C followed by washing of the cells. The effect of preincubation of PAPP-A or PAPP-A/proMBP complex with heparinase was also studied:
Recombinant PAPP-A containing supernatant or purified PAPP-A/proMBP complex (0.25 mg) was incubated for 1 h with 1 mIU/ml of heparinase I at 37 °C. To separate PAPP-A or PAPP-A/proMBP from the heparinase, PAPP-A mAb 234-2 immobilized on protein G argarose beads (Life Technologies) was added to the digest, followed by washing in 50 mM NaCl, 50 mM Tris, pH 7.5. PAPP-A antigen was then eluted with 0.1M glycine, pH 3.0, and the pH was adjusted to 7.5 by the addition of 0.5 M Tris. The concentrations of purified protein were measured by amino acid analysis. The absolute fluorescence varied for similar samples with the batch of secondary antibodies used, and with instrument settings, but all comparisons were made with these parameters kept constant.
Western Blotting -For immunovisualization of PAPP-A, protein separated by nonreducing SDS-PAGE (5-15% Tris-glycine gels), were blotted onto a polyvinylidene difluoride membrane (Millipore). Blots were allowed to dry, and then incubated with primary antibody (polyclonal anti(PAPP-A/proMBP) (25)) by guest on http://www.jbc.org/
Adhesion of pregnancy-associated plasma protein-A, PAGE 10 diluted in 10 mM sodium phosphate, 150 mM sodium chloride, 0.01% Tween 20, pH 7.2 (PBST) containing 2% (w/v) skimmed milk powder for 1 h at room temperature, according to the protocol of the manufacturer (Millipore). Blots were washed in PBST, and further incubated with secondary antibody (P217, DAKO) diluted in PBST with 2% (w/v) skimmed milk powder, and then washed again with PBST. The blots were developed using enhanced chemiluminescence (ECL, Amersham). Immunovisualization of proMBP following reducing SDS-PAGE was carried by the same procedure.
Measurement of Proteolytic Activity -Purified recombinant IGFBP-4 (3 µg) (17) was 125 I-labeled, and cleavage analysis was performed as previously described (13) . In brief, approximately 5 ng labeled (50.000 cpm) and 0.5 µg unlabeled IGFBP-4, with or without added molar excess of IGF-II (Bachem), was used for each reaction. PAPP-A bound to the surface of cells was prepared by incubating 293T cells (detached with PBS/5 mM EDTA, and preincubated with 1% paraformaldehyde for 12 h at 4 °C to minimize possible shedding of receptors) with PAPP-A (5 µg/ml) for 1 h on ice following thorough washing in 100 mM NaCl, 1 mM CaCl 2 , 50 mM Tris, pH 7.5 to remove unbound enzyme. The PAPP-A-binding cells were incubated with labeled IGFBP-4 and IGF-II in 100 mM NaCl, 1 mM CaCl 2 , 50 mM Tris, pH 7.5, for 1 h at 37 °C, and cleavage was visualized by reducing SDS-PAGE followed by autoradiography using a PhosphorImager (Molecular Dynamics). As a control, the PAPP-A activity contained in the supernatant following a 1 h incubation at 37 °C (without IGFBP-4 and IGF-II) was also measured. The experiment was also carried out with IGFBP-5 as the substrate (13) , and a similar experiment was performed using PAPP-A2 and IGFBP-5 (19) . In a parallel experiment, we analyzed the transient surface expression of integrin Mac-1, a transmembrane receptor, and found Mac-1 to be present only on about 50% of the cells (Fig. 1B) , which accounts for the fraction of cells successfully transfected. It thus appeared that cells in which proPAPP-A is not synthesized do also bind PAPP-A antigen, a finding supported by the marked difference in the distribution of cells in the two histograms (Fig. 1A vs. 1B) . We therefore analyzed cells transfected with cDNA encoding the mature PAPP-A polypeptide, known to be secreted into the medium. Because this experiment also demonstrated PAPP-A binding to the vast majority of the cells analyzed (Fig. 1C) , we conclude that the mature PAPP-A polypeptide is sufficient for cell surface binding. Adhesion of pregnancy-associated plasma protein-A, PAGE 12 When non-transfected 293T cells were incubated with culture supernatant containing recombinant PAPP-A, surface binding to all cells was evident, as determined by flow cytometry ( Fig. 2A) . Surface binding of PAPP-A was also observed when this experiment was carried out with JAR cells (Fig. 2B) , with BHK-21 cells (Fig. 2C) , or with JEG-3 cells (data not shown). In addition to these cell lines, we probed a primary culture of normal human skin fibroblasts (known to express very low levels of PAPP-A) (4). With these cells, PAPP-A surface adhesion was also demonstrated (Fig. 2D ).
In summary, we have shown that PAPP-A is capable of adherence to the cell surface, and that PAPP-A needs not be synthesized in a cell to which it binds. All cell types analyzed appeared to have the ability to bind PAPP-A. 2 , lacking the Cterminal third of the PAPP-A sequence, was unable to bind to the cell surface ( Fig. 3) . Importantly, the mAb used for flow cytometry did recognize the C1210STOP mutant in ELISA, verifying that PAPP-A surface binding, not the antibody epitope, had been lost. Expression of the C1210STOP mutant was also verified by
Adhesion is mediated by the C-terminal third of PAPP-
Western blotting (not shown).
Heparin and heparan sulfate inhibits surface binding of PAPP-A -As some SCR domains of other
proteins are known to bind glycosaminoglycan (GAG) (31), we tested the ability of heparin to inhibit surface binding of PAPP-A. Analysis by flow cytometry were carried out as previously, using non-transfected 293T
cells, but prior to incubation with the cells, PAPP-A was preincubated with heparin. As we found that heparin has a dramatic effect on PAPP-A adhesion (Fig. 4A ), the effect of other GAGs was also analyzed:
The effect of heparan sulfate was very similar to that of heparin. In both cases, PAPP-A binding was reduced > 95% at a GAG concentration of 25µg/ml ( Fig. 4A and 4B ). In contrast, the effect of both dermatan sulfate by guest on November 6, 2017
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Adhesion of pregnancy-associated plasma protein-A, PAGE 13 and chondroitin sulfate were relatively weak (Fig. 4B ). Thus, PAPP-A adhesion can be effectively inhibited by competing for binding to a GAG binding site, which appears to reside in the SCR region of PAPP-A.
Accordingly, we also found that removal of GAG from the cell surface, by pretreatment of the cells with heparinase, completely abrogated PAPP-A surface binding (Fig. 4C) . Furthermore, surface binding was also abrogated when cells were incubated first with PAPP-A, and then with heparin (not shown), demonstrating reversibility of PAPP-A surface binding. and 5B, lanes 3-4). However, the activities in the supernatants were much lower than the activities on the cell surface ( Fig. 5A , lanes 3 vs. 6, and 5B, lanes 2 vs. 4). We concluded that surface bound PAPP-A is active, and that it generates the same IGFBP-4 fragments whether immobilized to the cell surface or in solution.
PAPP-A attached to the surface of cells is proteolytically active
A similar experiment was carried out using PAPP-A2 and IGFBP-5 as the substrate. A suspension of cells preincubated with PAPP-A2 was proteolytically inactive against IGFBP-5 ( (19) . Adhesion of pregnancy-associated plasma protein-A, PAGE 14 advantage of the fact that PAPP-A2 is homologous (46% identical) to PAPP-A, but does not exhibit surface binding. We constructed two series PAPP-A/PAPP-A2 chimeras, in which variable sequence stretches of PAPP-A were replaced with the corresponding PAPP-A2 sequence.
Localization of the GAG binding site to SCR-3 and -4 using chimeras of PAPP-A and PAPP-A2
First, five chimeras (chim1-5) were made, in which a progressively longer portion of the C-terminal PAPP-A sequence was replaced with PAPP-A2 sequence (Fig. 6A) . Points of transition between PAPP-A and PAPP-A2 sequence were the N-terminal end of each of the SCR modules (Fig. 6A) . As judged by
Western blotting, all chimeras expressed as dimeric proteins, like wild-type PAPP-A (Fig. 7) . Chim1, containing PAPP-A2 SCR-5, bound 293T cells as well as wild-type PAPP-A. Chim2, in which SCR-4 is also substituted, showed only weak surface binding, and chim3, chim4, and chim5 did not show any surface binding (Fig. 6A) . Therefore, this experiment points at the involvement of SCR-3 and -4 in adhesion of PAPP-A.
Second, to further substantiate this interpretation, we replaced SCR-3 and -4 alone or together (chim6-8) (Fig. 6B) . Substituting PAPP-A SCR-3 domain alone with PAPP-A2 sequence completely abrogated surface binding (chim6), whereas replacement of SCR-4 alone resulted in a chimera with relatively weak binding (chim7), compared to wild-type PAPP-A. As expected, when SCR-3 and -4 were replaced at the same time (chim8), surface binding was lost. Finally, in chim9, sequence stretches on both sides of SCR-3 and -4 were replaced with PAPP-A2 sequence. This PAPP-A/PAPP-A2 chimera bound to the cell surface as well as did wild-type PAPP-A (Fig. 6B) . We conclude that the domains SCR-3 and -4 are not only required, but also sufficient, for efficient surface binding of PAPP-A. decreasing the probability that IGF is captured and inactivated before it binds to the receptor.
PAPP-A complexed to proMBP does not adhere to cells
Therefore, our finding that PAPP-A binds to the surface of cells (Fig. 1) suggests that this plays a part in targeting of its proteolytic activity. We demonstrated that PAPP-A is enzymatically active while bound to cells (Fig. 5) , and that PAPP-A synthesized in one cell can adhere to another (Fig. 2 ). Importantly, this allows possible functions of PAPP-A in both autocrine and paracrine mechanisms.
Based on preliminary localization of the PAPP-A binding site to the C-terminal third of PAPP-A (Fig. 3) , we speculated that glycosaminoglycan (GAG) is implicated in the surface binding of PAPP-A.
Indeed, we found that heparin effectively competes for the binding site on PAPP-A. The effect of heparan sulfate was very similar to that of heparin, but dermatan sulfate and chondroitin sulfate both competed inefficiently (Fig. 4) . These results suggests that a cell surface heparan sulfate proteoglycan (HSPG), In some cases, cell surface HSPGs function as co-receptors, efficiently increasing the interaction between a ligand, for example a growth factor, and its signaling receptor (36) . Although HSPG do not appear to function as a co-receptor for IGF, adhesion of PAPP-A indirectly increases the effective concentration of IGF in the vicinity of its receptor. However, the existence of a PAPP-A signaling receptor cannot be ruled out. Further, an internalization receptor, or a non-signaling co-receptor for PAPP-A, providing binding energy and/or specificity, may also exist.
We previously observed PAPP-A antigen in solubilized membranes of stimulated JAR cells (21), and other data have indicated that PAPP-A associates with preparations of membrane made from human placenta (37) . Although these data were carried out with polyspecific PAPP-A antibodies, known to recognize different antigens (22, 38) they are in agreement with our data. Furthermore, we have recently demonstrated that PAPP-A antigen present in a preparation of solubilized membranes from human trophoblasts is proteolytically active 3 .
A functional role in vivo of surface adhesion of a soluble proteinase has been demonstrated for matrilysin (MMP-7). MMP-7 binding of heparan sulfate was first established (39), and it was then shown that CD44, a facultative cell surface proteoglycan, binds both MMP-7 and its substrate, the precursor of heparin-binding epidermal growth factor (pro-HB-EGF). Within this assemblage, mature HB-EGF is generated in close proximity to its receptor, ErbB4 (40) . Another example, also with similarity to the system of IGF, IGFBP-4, and PAPP-A, is the activation of transforming growth factor-β (TGF-β) by surface bound MMP-9 (41). Other nontransmembrane metzincins have been found to associate with the cell surface, although they do not appear to function in growth factor activation: MMP-2 binds integrin αvβ3 promoting cellular invasion (42) , and MMP-2 binds a clearance receptor, proposed to regulate extracellular activity of this enzyme (43) . Adhesion of MMP-19 has also been shown, although its function is not known (44) .
Further, the serine proteinase plasmin, potentially activated at the cell surface, has been shown to be capable of degrading IGFBPs, independent of the presence of IGF (45, 46) , but the physiological significance of plasmin in the IGF system is not known.
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Adhesion of pregnancy-associated plasma protein-A, PAGE 18 To further define the GAG binding site of PAPP-A, nine chimeras of PAPP-A and PAPP-A2 were constructed and analyzed (Fig. 6 ). We found that both SCR-3 and -4 are involved in PAPP-A surface binding. There may be a separate GAG binding sites on each of these domains, or there may be single site, to which both SCR-3 and -4 make contributions. In either case, the residues of SCR-3 appear to be more important, as chim6, in which SCR-3 alone is substituted with PAPP-A2 sequence, did not bind, and as chim7, in which SCR-4 only is replaced, showed weak binding (Fig. 6) . The true modularity of the SCR domain is debated (33), and we cannot exclude that inter-domain interactions are disturbed in some of the chimeras. It is therefore important that no result contradicts the above interpretation, which is based on both knock-out and knock-in experiments.
SCR domains (also called CCP modules) are best known from their presence in complement control proteins such as factor H (fH), which is composed of 20 SCR modules alone (33); SCR domain 16 of fH was the first to have its three-dimensional structure solved (47) . The SCR domain is a five-stranded β-sandwich structure, and individual domains are linked in a head-to-tail manner with varying angels between the axes of each domain (33) .
Factor H is known to bind heparin, and the heparin binding has been mapped to individual SCR domains (7, 13, and 20) (48) . Complexes between SCR domain(s) and GAG have not yet been studied at atomic resolution, but the binding of heparin to other proteins, such as antithrombin and fibroblast growth factors, has been studied in detail by X-ray crystallography (49). It is therefore known that residues with positively charged side chains interact with GAG sulfate groups. Vaccinia virus complement control protein (VCP) contains four SCR domains, and is also known to bind heparin. Its recently reported crystal structure (31) reveals two patches of positive residues. Interestingly, the one is at the end of domain 4, the other straddles domains 1 and 2.
SCR-3 of PAPP-A contains 13 residues with basic side chains (18) , whereas SCR-3 of PAPP-A2
contains only six (19) . The average number of basic residues in the 10 SCR modules of PAPP-A and PAPP-A2 is five; PAPP-A SCR-4 has five basic residues. These figures clearly point at direct interactions between by guest on November 6, 2017
Adhesion of pregnancy-associated plasma protein-A, PAGE 19 GAG and residues of PAPP-A SCR-3, but further mutagenesis, focusing at single amino acids, will be required to define the PAPP-A-GAG interactions in greater detail.
As proMBP is known to be substituted with a heparan sulfate GAG (26) 1-4) or PAPP-A2 (lanes 5-6). All reaction mixtures were analyzed by SDS-PAGE followed by autoradiography. C-terminal tags on both protein substrates causes their cleavage products to co-migrate, and thus appear as one band (13).
FIG. 6. Localization of surface binding site to PAPP-A domains SCR-3 and -4.
Based on the result of Laursen et al. Figure 7 
